check_circleStudy Completed
Postmenopause, Hormone Replacement Therapy
Bayer Identifier:
91052
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study to assess safety of a hormone therapy preparation containing Drospirenone/Estradiol in women with concomitant disease and medication known to potentate the risk of hyperkalemia
Trial purpose
Please see attached Study Results Summary below.
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
230Trial Dates
December 2001 - March 2003Phase
Phase 3Could I Receive a placebo
N/AProducts
Angeliq (E2/DRSP, BAY86-4891)Accepts Healthy Volunteer
N/APrimary Outcome
Secondary Outcome
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A